• SPX
  • $5,631.45
  • -0.03 %
  • -$1.64
  • DJI
  • $41,568.05
  • -0.13 %
  • -$54.04
  • N225
  • $36,203.22
  • -1.03 %
  • -$378.54
  • FTSE
  • $8,309.86
  • 0.38 %
  • $31.42
  • IXIC
  • $17,589.87
  • -0.01 %
  • -$2.25
Revvity, Inc. (RVTY) Stock Price, News & Analysis

Revvity, Inc. (RVTY) Stock Price, News & Analysis

Currency in USD Disclaimer

$121.95

-$0.85

(-0.69%)

Day's range
$121.28
Day's range
$123.5
50-day range
$102.88
Day's range
$128.15
  • Country: US
  • ISIN: US7140461093
52 wk range
$79.5
Day's range
$128.15
  • CEO: Dr. Prahlad R. Singh Ph.D.
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 2.66
  • Piotroski Score 7.00
  • Grade Neutral
  • Symbol (RVTY)
  • Company Revvity, Inc.
  • Price $121.95
  • Changes Percentage (-0.69%)
  • Change -$0.85
  • Day Low $121.28
  • Day High $123.50
  • Year High $128.15

Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

  • Last Earnings 07/25/2024
  • Ex-Dividend for 5/16 Dividend 10/18/2024
  • Dividend Payable 11/08/2024
  • Today N/A
  • Next Earnings (Estimated) 10/28/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $125.50
  • High Stock Price Target $135.00
  • Low Stock Price Target $110.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $1.47
  • Trailing P/E Ratio 75.46
  • Forward P/E Ratio 75.46
  • P/E Growth 75.46
  • Net Income $179.50 M

Income Statement

Quarterly

Annual

Latest News of RVTY

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.